A Phase 1, Open-label, Randomized, Two-period, Two-treatment, Crossover Study to Evaluate the Effect of Bexagliflozin on the Pharmacokinetics of Digoxin in Healthy Subjects

Trial Profile

A Phase 1, Open-label, Randomized, Two-period, Two-treatment, Crossover Study to Evaluate the Effect of Bexagliflozin on the Pharmacokinetics of Digoxin in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Sep 2017

At a glance

  • Drugs Bexagliflozin (Primary) ; Digoxin
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Theracos
  • Most Recent Events

    • 21 Sep 2017 Status changed to completed.
    • 20 Jul 2017 Planned End Date changed from 17 Aug 2017 to 17 Sep 2017.
    • 20 Jul 2017 Planned primary completion date changed from 17 Aug 2017 to 17 Sep 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top